- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/92 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 211/92
Total number of patents in this class: 43
10-year publication summary
4
|
1
|
4
|
3
|
2
|
1
|
2
|
2
|
1
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes Pharma Ireland Limited | 270 |
4 |
ChemoCentryx, Inc. | 386 |
3 |
Bayer Intellectual Property GmbH | 2498 |
2 |
Albert Einstein College of Medicine, Inc. | 576 |
2 |
Kobelco Eco-solutions Co., Ltd. | 126 |
2 |
Corteva Agriscience LLC | 2682 |
2 |
3m Innovative Properties Company | 17823 |
1 |
The Regents of the University of California | 19961 |
1 |
Merck Sharp & Dohme Corp. | 2191 |
1 |
Massachusetts Institute of Technology | 10062 |
1 |
Bridgestone Corporation | 7235 |
1 |
Board of Regents, The University of Texas System | 5808 |
1 |
President and Fellows of Harvard College | 5986 |
1 |
Vertex Pharmaceuticals Incorporated | 1600 |
1 |
Duke University | 3069 |
1 |
Albert Einstein College of Medicine of Yeshiva University | 148 |
1 |
Chiesi Farmaceutici S.p.A. | 965 |
1 |
Immunolight, LLC | 208 |
1 |
Khondrion IP B.V. | 19 |
1 |
Microbial Chemistry Research Foundation | 79 |
1 |
Other owners | 14 |